The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury. (2022)
Attributed to:
Engaging and creating “Influencers” within an academic-industry environment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ctm2.962
PubMed Identifier: 35818848
Publication URI: http://europepmc.org/abstract/MED/35818848
Type: Journal Article/Review
Volume: 12
Parent Publication: Clinical and translational medicine
Issue: 7
ISSN: 2001-1326